Logo

Balaxi Pharmaceuticals Ltd. Share Price

Trading

Balaxi Pharmaceuticals Ltd. (INR)58.37-1.9   (-3.2%)

Exchange ScripsBSENSEBALAXIISININE618N01022

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Balaxi Pharmaceuticals Ltd. Performance

Market performance

Open price60.98
High61.09
Volumes174540
Prev Close58.37
Low57
Closing date2025-04-25

Historical performance

1 Year High151.45
3 Year High151.45
5 Year High216.04
1 Year Low50.42
3 Year Low50.42
5 Year Low13.01

Balaxi Pharmaceuticals Ltd. Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
322
Face Value
Face Value (₹)
2
P/E Ratio
P/E Ratio
87.13
Dividend Yield
Dividend Yield
N/A

Balaxi Pharmaceuticals Ltd. Investment Returns

1 Year
-49.3%
3 Years
-36.5%
5 Years
288.4%
10 Years
N/A

Balaxi Pharmaceuticals Ltd. Technicals

IndicatorsValueSignal
5-DMA61.32Bearish
10-DMA63.88Bearish
20-DMA64.97Bearish
50-DMA63.59Bearish
100-DMA69.43Bearish
200-DMA85.72Bearish

Shareholding Pattern

FieldMar-2025Dec-2024Sep-2024Jun-2024Mar-2024
Promoters33333
Foreign Investors---------------
Domestic Investors33333
Public Investors99918526786065835203
Government---------------

Balaxi Pharmaceuticals Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income6265022
Operating Profit452601558449
Interest281483
Depreciation211853
Profit Before Tax20569545443
Consolidated Net Profit-73517482372
Adjusted EPS-110107

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital109102100100
Total Reserves186716241032550
Minority Interest------------
Total Non-Current Liabilities2837------
Total Liabilities258323971765997
Capital Work in Progress23286---
Total Assets258323971765997

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities4961341---
Cash Flow from Investing Activities-10-106-284-60
Cash Flow from Financing Activitie303255-236
Net Cash Inflow / Outflow34121055-23
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 87.13.
  • 3Y Stock Price CAGR of the stock is -14.9.
  • The stock has a beta of 1.2.
  • In the last financial year, the company had an EBITDA of ₹78 Million.
  • The company generated revenue of ₹702 Million in the previous financial year.

Balaxi Pharmaceuticals Ltd.

58.37-1.9   (-3.2%)

Investment Amount: ₹ 1000000
Current Value: ₹ 483355.4
No. of Shares: 8280.9
Performance:-51.7%
P/L: ₹-516644.6

Top Gainers

SymbolChange%
LFIC203.61(20%)
CARRARO386.55(17%)
MANAKSTEEL73.32(15%)
BUTTERFLY700.45(15%)
COUNCODOS10.84(10%)

Top Losers

SymbolChange%
SRM321.35(-11%)
BHANDARI4.85(-11%)
MINDTECK208.55(-10%)
OSWALAGRO87.03(-9%)
PVP25.67(-9%)
AMDIND46.95(-9%)
MAGNUM27.9(-9%)
PAVNAIND322.75(-8%)

Similar stocks

Sakuma Exports Ltd.

37.8

3.46

March 26 - April 26

Compuage Infocom Ltd.

35.1

2

March 26 - April 26

Lloyds Enterprises Ltd.

26.1

53.05

March 26 - April 26

Spacenet Enterprises India Ltd.

25

8.61

March 26 - April 26

Oswal Agro Mills Ltd.

18.3

87.03

March 26 - April 26

Kamdhenu Ventures Ltd.

18

11.42

March 26 - April 26

TVS Electronics Ltd.

17.4

390.95

March 26 - April 26

Entero Healthcare Solutions Ltd.

17

1322.6

March 26 - April 26

Announcing Stock of the Month!

Stock of the Month
Stock of the Month